Physician profile
Vijay Devireddy
NPI 1407239148
$419.74
in general payments reported to CMS, 2019-2025
8 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $168.17 | 2025 | Jardiance, Zepbound, Mounjaro |
| Pfizer INC. | $69.20 | 2025 | |
| Astellas Pharma US INC | $60.52 | 2025 | Veozah |
| Amgen INC. | $51.19 | 2025 | Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.34 | 2025 | Xifaxan |
| Novo Nordisk INC | $17.42 | 2025 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $17.09 | 2025 | The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $15.81 | 2025 | Vaxneuvance, M-M-R II, Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijay Devireddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.